Toll Free: 1-888-928-9744

Global mRNA Vaccines & Therapeutics Market Research Report 2017-2022 by Players, Regions, Product Types & Applications

Published: Aug 9, 2017 | Pages: 112 | Publisher: Data Market Research (DMR) | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The global mRNA Vaccines & Therapeutics market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

This report offers an overview of the market trends, drivers, and barriers with respect to the mRNA Vaccines & Therapeutics market. It also provides a detailed overview of the market of different regions across United States, Europe, China, Japan, India, Southeast Asia and Others. The report categorizes mRNA Vaccines & Therapeutics market by By Cancer Vaccines, By Infectious Disease Vaccines, By In vivo Therapeutics, By Gene Editing, and application. Detailed analysis of key players, along with key growth strategies adopted by them is also covered in this report on mRNA Vaccines & Therapeutics market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

This report focuses Global market, it covers details as following:

Key Players
    Argos Therapeutics (U.S.)
    AstraZeneca (UK)
    Bayer AG (Germany)
    BioNTech (Germany)
    Boehringer Ingelheim (Germany)
    CRISPR Therapeutics (Switzerland)
    CureVac (Germany)
    ETheRNA immunotherapies (Belgium)
    Ethris (Germany)
    GlaxoSmithKline Vaccines (UK)
    In-Cell-Art (France)
    Intellia Therapeutics (U.S.)
    Janssen (Belhium)
    Kernal Biologics (U.S.)
    MaxCyte (U.S.)
    Moderna Therapeutics (U.S.)
    Novartis (U.S.)
    PhaseRx (U.S.)
    Precision NanoSystems (Canada)
    RaNa Therapeutics (U.S.)

Key Regions
    North America
        United States
        Canada
    Latin America
        Mexico
        Brazil
        Argentina
        Others
    Europe
        Germany
        United Kingdom
        France
        Italy
        Spain
        Russia
        Netherland
        Others
    Asia & Pacific
        China
        Japan
        India
        Korea
        Australia
        Southeast Asia
            Indonesia
            Thailand
            Philippines
            Vietnam
            Singapore
            Malaysia
            Others
    Africa & Middle East
        South Africa
        Egypt
        Turkey
        Saudi Arabia
        Iran
        Others

Main types of products
mRNA Vaccines & Therapeutics Market, by Cancer Vaccines
    Standardized preselected
    Individualized shared antigens
    Individualized neoantigens
mRNA Vaccines & Therapeutics Market, by Infectious Disease Vaccines
    Prophylactic vaccines
    Therapeutic vaccines
    Synthetic self-amplifying mRNA vaccines for pandemic outbreaks
mRNA Vaccines & Therapeutics Market, by In vivo Therapeutics
    Therapeutic proteins
    Therapeutic antibodies
mRNA Vaccines & Therapeutics Market, by Gene Editing
    Ex vivo gene editing of gene defects
    In vivo gene editing of gene defects
    Ex vivo gene editing of autologous and allogeneic T-cells

mRNA Vaccines & Therapeutics Market, by Key Consumer
    Hospital
    Clinic
    Others

 Table of Contents

Global mRNA Vaccines & Therapeutics Market Research Report 2017-2022 by Players, Regions, Product Types & Applications
Chapter One Methodology and Data Source
    1.1 Methodology/Research Approach
        1.1.1 Research Programs/Design
        1.1.2 Market Size Estimation
        1.1.3 Market Breakdown and Data Triangulation
    1.2 Data Source
        1.2.1 Secondary Sources
        1.2.2 Primary Sources
    1.3 Disclaimer

Chapter Two mRNA Vaccines & Therapeutics Market Overview
    2.1 Market Coverage
    2.2 Global mRNA Vaccines & Therapeutics Market Sales Volume Revenue and Price 2012-2017

Chapter Three mRNA Vaccines & Therapeutics by Key Players 2012-2017
    3.1 Global mRNA Vaccines & Therapeutics Sales Volume Market Share by Key Players 2012-2017
    3.2 Global mRNA Vaccines & Therapeutics Revenue Share by Key Players 2012-2017
    3.3 Global Key Players mRNA Vaccines & Therapeutics Key Product Model and Market Performance
    3.4 Global Key Players mRNA Vaccines & Therapeutics Key Target Consumers and Market Performance

Chapter Four mRNA Vaccines & Therapeutics by Regions 2012-2017
    4.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Regions 2012-2017
    4.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions 2012-2017
    4.3 Global mRNA Vaccines & Therapeutics Price by Regions 2012-2017
    4.4 North America
        4.4.1 United States
        4.4.2 Canada
    4.5 Latin America
        4.5.1 Mexico
        4.5.2 Brazil
        4.5.3 Argentina
        4.5.4 Others in Latin America
    4.6 Europe
        4.6.1 Germany
        4.6.2 United Kingdom
        4.6.3 France
        4.6.4 Italy
        4.6.5 Spain
        4.6.6 Russia
        4.6.7 Netherland
        4.6.8 Others in Europe
    4.7 Asia & Pacific
        4.7.1 China
        4.7.2 Japan
        4.7.3 India
        4.7.4 Korea
        4.7.5 Australia
        4.7.6 Southeast Asia
            4.7.6.1 Indonesia
            4.7.6.2 Thailand
            4.7.6.3 Philippines
            4.7.6.4 Vietnam
            4.7.6.5 Singapore
            4.7.6.6 Malaysia
            4.7.6.7 Others in Southeast Asia
    4.8 Africa & Middle East
        4.8.1 South Africa
        4.8.2 Egypt
        4.8.3 Turkey
        4.8.4 Saudi Arabia
        4.8.5 Iran
        4.8.6 Others in Africa & Middle East

Chapter Five mRNA Vaccines & Therapeutics Market by Product Types
    5.1 mRNA Vaccines & Therapeutics, by Cancer Vaccines 2012-2017
        5.1.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Cancer Vaccines 2012-2017
        5.1.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Cancer Vaccines 2012-2017
        5.1.3 Global mRNA Vaccines & Therapeutics Price by Cancer Vaccines 2012-2017
        5.1.4 Standardized preselected
        5.1.5 Individualized shared antigens
        5.1.6 Individualized neoantigens
    5.2 mRNA Vaccines & Therapeutics, by Infectious Disease Vaccines 2012-2017
        5.2.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Infectious Disease Vaccines 2012-2017
        5.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Infectious Disease Vaccines 2012-2017
        5.2.3 Global mRNA Vaccines & Therapeutics Price by Infectious Disease Vaccines 2012-2017
        5.2.4 Prophylactic vaccines
        5.2.5 Therapeutic vaccines
        5.2.6 Synthetic self-amplifying mRNA vaccines for pandemic outbreaks
    5.3 mRNA Vaccines & Therapeutics, by In vivo Therapeutics 2012-2017
        5.3.1 Global mRNA Vaccines & Therapeutics Sales Market Share by In vivo Therapeutics 2012-2017
        5.3.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by In vivo Therapeutics 2012-2017
        5.3.3 Global mRNA Vaccines & Therapeutics Price by In vivo Therapeutics 2012-2017
        5.3.4 Therapeutic proteins
        5.3.5 Therapeutic antibodies
    5.4 mRNA Vaccines & Therapeutics, by Gene Editing 2012-2017
        5.4.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Gene Editing 2012-2017
        5.4.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Gene Editing 2012-2017
        5.4.3 Global mRNA Vaccines & Therapeutics Price by Gene Editing 2012-2017
        5.4.4 Ex vivo gene editing of gene defects
        5.4.5 In vivo gene editing of gene defects
        5.4.6 Ex vivo gene editing of autologous and allogeneic T-cells

Chapter Six Global Key Players Profile
    6.1 Argos Therapeutics (U.S.)
        6.1.1 Argos Therapeutics (U.S.) Company Details and Competitors
        6.1.2 Argos Therapeutics (U.S.) Key mRNA Vaccines & Therapeutics Models and Performance
        6.1.3 Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
        6.1.4 Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
    6.2 AstraZeneca (UK)
        6.2.1 AstraZeneca (UK) Company Details and Competitors
        6.2.2 AstraZeneca (UK) Key mRNA Vaccines & Therapeutics Models and Performance
        6.2.3 AstraZeneca (UK) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
        6.2.4 AstraZeneca (UK) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
    6.3 Bayer AG (Germany)
        6.3.1 Bayer AG (Germany) Company Details and Competitors
        6.3.2 Bayer AG (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
        6.3.3 Bayer AG (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
        6.3.4 Bayer AG (Germany) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
    6.4 BioNTech (Germany)
        6.4.1 BioNTech (Germany) Company Details and Competitors
        6.4.2 BioNTech (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
        6.4.3 BioNTech (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
        6.4.4 BioNTech (Germany) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
    6.5 Boehringer Ingelheim (Germany)
        6.5.1 Boehringer Ingelheim (Germany) Company Details and Competitors
        6.5.2 Boehringer Ingelheim (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
        6.5.3 Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
        6.5.4 Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
    6.6 CRISPR Therapeutics (Switzerland)
        6.6.1 CRISPR Therapeutics (Switzerland) Company Details and Competitors
        6.6.2 CRISPR Therapeutics (Switzerland) Key mRNA Vaccines & Therapeutics Models and Performance
        6.6.3 CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
        6.6.4 CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
    6.7 CureVac (Germany)
        6.7.1 CureVac (Germany) Company Details and Competitors
        6.7.2 CureVac (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
        6.7.3 CureVac (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
        6.7.4 CureVac (Germany) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
    6.8 ETheRNA immunotherapies (Belgium)
        6.8.1 ETheRNA immunotherapies (Belgium) Company Details and Competitors
        6.8.2 ETheRNA immunotherapies (Belgium) Key mRNA Vaccines & Therapeutics Models and Performance
        6.8.3 ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
        6.8.4 ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
    6.9 Ethris (Germany)
        6.9.1 Ethris (Germany) Company Details and Competitors
        6.9.2 Ethris (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
        6.9.3 Ethris (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
        6.9.4 Ethris (Germany) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
    6.10 GlaxoSmithKline Vaccines (UK)
        6.10.1 GlaxoSmithKline Vaccines (UK) Company Details and Competitors
        6.10.2 GlaxoSmithKline Vaccines (UK) Key mRNA Vaccines & Therapeutics Models and Performance
        6.10.3 GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
        6.10.4 GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
    6.11 In-Cell-Art (France)
    6.12 Intellia Therapeutics (U.S.)
    6.13 Janssen (Belhium)
    6.14 Kernal Biologics (U.S.)
    6.15 MaxCyte (U.S.)
    6.16 Moderna Therapeutics (U.S.)
    6.17 Novartis (U.S.)
    6.18 PhaseRx (U.S.)
    6.19 Precision NanoSystems (Canada)
    6.20 RaNa Therapeutics (U.S.)

Chapter Seven mRNA Vaccines & Therapeutics by Appliance 2012-2017
    7.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Appliance 2012-2017
    7.2 Hospital
    7.3 Clinic
    7.4 Others
    7.5 Consuming Habit and Preference

Chapter Eight Industry Chain and Supply Chain
    8.1 mRNA Vaccines & Therapeutics Industry Chain Structure
        8.1.1 R&D
        8.1.2 Raw Materials (Components)
        8.1.3 Manufacturing Plants
        8.1.4 Regional Trading (Import Export and Local Sales)
        8.1.5 Online Sales Channel
        8.1.6 Offline Channel
        8.1.7 End Users
    8.2 mRNA Vaccines & Therapeutics Manufacturing
        8.2.1 Key Components
        8.2.2 Assembly Manufacturing
    8.3 Consumer Preference
    8.4 Behavioral Habits
    8.5 Marketing Environment

Chapter Nine Global mRNA Vaccines & Therapeutics Market Size (Sales and Revenue) Forecast (2017-2022)
    9.1 Global mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
    9.2 Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Regions (2017-2022)
    9.3 Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Application (2017-2022)
    9.4 Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Cancer Vaccines (2017-2022)
    9.5 Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Infectious Disease Vaccines (2017-2022)
    9.6 Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by In vivo Therapeutics (2017-2022)
    9.7 Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Gene Editing (2017-2022)

Chapter Ten Development Trend and Research Conclusion
    10.1 Development Trend
    10.2 Research Conclusion


List of Tables and Figures

    Table Global mRNA Vaccines & Therapeutics Sales Volume (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume (K Units) and Growth Rate (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales Volume (K Units) by Key Players (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales Volume Market Share by Key Players (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share by Key Players 2016
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share by Key Players 2017
    Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) by Key Players (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Revenue Market Share by Key Players (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Key Players 2016
    Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Key Players 2017
    Table Global Key Players Key Product Model and Market Performance
    Table Global Key Players Key Target Consumers and Market Performance
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) by Regions (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales Share by Regions (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Regions in 2016
    Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Regions in 2017
    Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) by Regions (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions in 2016
    Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions in 2017
    Table Global mRNA Vaccines & Therapeutics Price (USD/Unit) by Regions (2012-2017)
    Table North America mRNA Vaccines & Therapeutics Sales (K Units) by Regions (2012-2017)
    Table North America mRNA Vaccines & Therapeutics Revenue (Million USD) by Regions (2012-2017)
    Table North America mRNA Vaccines & Therapeutics Sales Volume (K Units) by Key Players 2012-2017
    Figure North America mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Latin America mRNA Vaccines & Therapeutics Sales (K Units) by Regions (2012-2017)
    Table Latin America mRNA Vaccines & Therapeutics Revenue (Million USD) by Regions (2012-2017)
    Table Latin America mRNA Vaccines & Therapeutics Sales Volume (K Units) by Key Players (2012-2017)
    Figure Latin America mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Europe mRNA Vaccines & Therapeutics Sales (K Units) by Regions (2012-2017)
    Table Europe mRNA Vaccines & Therapeutics Revenue (Million USD) by Regions (2012-2017)
    Table Europe mRNA Vaccines & Therapeutics Sales Volume (K Units) by Key Players (2012-2017)
    Figure Europe mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Asia & Pacific mRNA Vaccines & Therapeutics Sales (K Units) by Regions (2012-2017)
    Table Asia & Pacific mRNA Vaccines & Therapeutics Revenue (Million USD) by Regions (2012-2017)
    Table Asia & Pacific mRNA Vaccines & Therapeutics Sales Volume (K Units) by Key Players (2012-2017)
    Figure Asia & Pacific mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Africa & Middle East mRNA Vaccines & Therapeutics Sales (K Units) by Regions (2012-2017)
    Table Africa & Middle East mRNA Vaccines & Therapeutics Revenue (Million USD) by Regions (2012-2017)
    Table Africa & Middle East mRNA Vaccines & Therapeutics Sales Volume (K Units) by Key Players (2012-2017)
    Figure Africa & Middle East mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) by Cancer Vaccines (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales Market Share by Cancer Vaccines (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Cancer Vaccines in 2016
    Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) by Cancer Vaccines (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Revenue Market Share by Cancer Vaccines (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Cancer Vaccines in 2016
    Table Global mRNA Vaccines & Therapeutics Price (USD/Unit) by Cancer Vaccines (2012-2017)
    Table Top Players of Standardized preselected mRNA Vaccines & Therapeutics Products List
    Figure Global Standardized preselected mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Top Players of Individualized shared antigens mRNA Vaccines & Therapeutics Products List
    Figure Global Individualized shared antigens mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Top Players of Individualized neoantigens mRNA Vaccines & Therapeutics Products List
    Figure Global Individualized neoantigens mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) by Infectious Disease Vaccines (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales Market Share by Infectious Disease Vaccines (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Infectious Disease Vaccines in 2016
    Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) by Infectious Disease Vaccines (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Revenue Market Share by Infectious Disease Vaccines (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Infectious Disease Vaccines in 2016
    Table Global mRNA Vaccines & Therapeutics Price (USD/Unit) by Infectious Disease Vaccines (2012-2017)
    Table Top Players of Prophylactic vaccines mRNA Vaccines & Therapeutics Products List
    Figure Global Prophylactic vaccines mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Top Players of Therapeutic vaccines mRNA Vaccines & Therapeutics Products List
    Figure Global Therapeutic vaccines mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Top Players of Synthetic self-amplifying mRNA vaccines for pandemic outbreaks mRNA Vaccines & Therapeutics Products List
    Figure Global Synthetic self-amplifying mRNA vaccines for pandemic outbreaks mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) by In vivo Therapeutics (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales Market Share by In vivo Therapeutics (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Sales Market Share by In vivo Therapeutics in 2016
    Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) by In vivo Therapeutics (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Revenue Market Share by In vivo Therapeutics (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by In vivo Therapeutics in 2016
    Table Global mRNA Vaccines & Therapeutics Price (USD/Unit) by In vivo Therapeutics (2012-2017)
    Table Top Players of Therapeutic proteins mRNA Vaccines & Therapeutics Products List
    Figure Global Therapeutic proteins mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Top Players of Therapeutic antibodies mRNA Vaccines & Therapeutics Products List
    Figure Global Therapeutic antibodies mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) by Gene Editing (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales Market Share by Gene Editing (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Gene Editing in 2016
    Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) by Gene Editing (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Revenue Market Share by Gene Editing (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Gene Editing in 2016
    Table Global mRNA Vaccines & Therapeutics Price (USD/Unit) by Gene Editing (2012-2017)
    Table Top Players of Ex vivo gene editing of gene defects mRNA Vaccines & Therapeutics Products List
    Figure Global Ex vivo gene editing of gene defects mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Top Players of In vivo gene editing of gene defects mRNA Vaccines & Therapeutics Products List
    Figure Global In vivo gene editing of gene defects mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Top Players of Ex vivo gene editing of autologous and allogeneic T-cells mRNA Vaccines & Therapeutics Products List
    Figure Global Ex vivo gene editing of autologous and allogeneic T-cells mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) by  (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales Market Share by  (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Sales Market Share by  in 2016
    Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) by  (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Revenue Market Share by  (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by  in 2016
    Table Global mRNA Vaccines & Therapeutics Price (USD/Unit) by  (2012-2017)
    Table Argos Therapeutics (U.S.) Company Details and Competitors
    Table Argos Therapeutics (U.S.) Key mRNA Vaccines & Therapeutics Models and Performance
    Table Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
    Table Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Sales Market Share (%) in Global (2012-2017)
    Figure Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Global (2012-2017)
    Table AstraZeneca (UK) Company Details and Competitors
    Table AstraZeneca (UK) Key mRNA Vaccines & Therapeutics Models and Performance
    Table AstraZeneca (UK) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
    Table AstraZeneca (UK) mRNA Vaccines & Therapeutics Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure AstraZeneca (UK) mRNA Vaccines & Therapeutics Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure AstraZeneca (UK) mRNA Vaccines & Therapeutics Sales Market Share (%) in Global (2012-2017)
    Figure AstraZeneca (UK) mRNA Vaccines & Therapeutics Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure AstraZeneca (UK) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Global (2012-2017)
    Table Bayer AG (Germany) Company Details and Competitors
    Table Bayer AG (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
    Table Bayer AG (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
    Table Bayer AG (Germany) mRNA Vaccines & Therapeutics Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure Bayer AG (Germany) mRNA Vaccines & Therapeutics Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Bayer AG (Germany) mRNA Vaccines & Therapeutics Sales Market Share (%) in Global (2012-2017)
    Figure Bayer AG (Germany) mRNA Vaccines & Therapeutics Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Bayer AG (Germany) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Global (2012-2017)
    Table BioNTech (Germany) Company Details and Competitors
    Table BioNTech (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
    Table BioNTech (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
    Table BioNTech (Germany) mRNA Vaccines & Therapeutics Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure BioNTech (Germany) mRNA Vaccines & Therapeutics Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure BioNTech (Germany) mRNA Vaccines & Therapeutics Sales Market Share (%) in Global (2012-2017)
    Figure BioNTech (Germany) mRNA Vaccines & Therapeutics Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure BioNTech (Germany) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Global (2012-2017)
    Table Boehringer Ingelheim (Germany) Company Details and Competitors
    Table Boehringer Ingelheim (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
    Table Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
    Table Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Sales Market Share (%) in Global (2012-2017)
    Figure Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Global (2012-2017)
    Table CRISPR Therapeutics (Switzerland) Company Details and Competitors
    Table CRISPR Therapeutics (Switzerland) Key mRNA Vaccines & Therapeutics Models and Performance
    Table CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
    Table CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Sales Market Share (%) in Global (2012-2017)
    Figure CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Global (2012-2017)
    Table CureVac (Germany) Company Details and Competitors
    Table CureVac (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
    Table CureVac (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
    Table CureVac (Germany) mRNA Vaccines & Therapeutics Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure CureVac (Germany) mRNA Vaccines & Therapeutics Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure CureVac (Germany) mRNA Vaccines & Therapeutics Sales Market Share (%) in Global (2012-2017)
    Figure CureVac (Germany) mRNA Vaccines & Therapeutics Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure CureVac (Germany) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Global (2012-2017)
    Table ETheRNA immunotherapies (Belgium) Company Details and Competitors
    Table ETheRNA immunotherapies (Belgium) Key mRNA Vaccines & Therapeutics Models and Performance
    Table ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
    Table ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Sales Market Share (%) in Global (2012-2017)
    Figure ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Global (2012-2017)
    Table Ethris (Germany) Company Details and Competitors
    Table Ethris (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
    Table Ethris (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
    Table Ethris (Germany) mRNA Vaccines & Therapeutics Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure Ethris (Germany) mRNA Vaccines & Therapeutics Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Ethris (Germany) mRNA Vaccines & Therapeutics Sales Market Share (%) in Global (2012-2017)
    Figure Ethris (Germany) mRNA Vaccines & Therapeutics Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Ethris (Germany) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Global (2012-2017)
    Table GlaxoSmithKline Vaccines (UK) Company Details and Competitors
    Table GlaxoSmithKline Vaccines (UK) Key mRNA Vaccines & Therapeutics Models and Performance
    Table GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
    Table GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Sales Market Share (%) in Global (2012-2017)
    Figure GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Global (2012-2017)
    Table In-Cell-Art (France) Company Details and Competitors
    Table Intellia Therapeutics (U.S.) Company Details and Competitors
    Table Janssen (Belhium) Company Details and Competitors
    Table Kernal Biologics (U.S.) Company Details and Competitors
    Table MaxCyte (U.S.) Company Details and Competitors
    Table Moderna Therapeutics (U.S.) Company Details and Competitors
    Table Novartis (U.S.) Company Details and Competitors
    Table PhaseRx (U.S.) Company Details and Competitors
    Table Precision NanoSystems (Canada) Company Details and Competitors
    Table RaNa Therapeutics (U.S.) Company Details and Competitors
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) by Appliance (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Appliance (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Appliance in 2016
    Figure Global Hospital mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Figure Global Clinic mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Figure Global Others mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Price (USD/Unit) Trend Forecast (2017-2022)
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Regions (2017-2022)
    Table Global mRNA Vaccines & Therapeutics Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Share Forecast by Regions in 2022
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Application (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Application in 2022
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Cancer Vaccines (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Cancer Vaccines (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Cancer Vaccines in 2022
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Infectious Disease Vaccines (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Infectious Disease Vaccines (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Infectious Disease Vaccines in 2022
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by In vivo Therapeutics (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by In vivo Therapeutics (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by In vivo Therapeutics in 2022
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Gene Editing (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Gene Editing (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Gene Editing in 2022

 



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global embedded system market is projected to be valued at USD 214.39 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising demand from end-use industries such as automotive and healthcare coupled with emergence of Internet o

Read More...

Global air traffic control equipment market is projected to reach USD 4.2 billion by 2020, as per a new research report by Radiant Insights, Inc. Mounting price sensitivity among customers with introduction of low fare airlines is expected to drive t

Read More...

Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanom

Read More...

Global FPGA market is anticipated to be valued at USD 9,882.5 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing demand for customized IC’s is expected to drive the demand. Customized IC’s helps manufacturers to mo

Read More...

Global aquafeed market size is anticipated to be valued at USD 165.04 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in fish consumption for direct and indirect consumer applications is anticipated to drive the marke

Read More...
Choose License Type
Single User - US $2380
Multi User - US $4780
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify